IGIM
BIIB icon

I.G. Investment Management’s Biogen BIIB Stock Holding History

I.G. Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$26.3M Buy
83,950
+41,497
+98% +$12.3M 0.13% 95
2017
Q2 		$11.5M Sell
42,453
-9,800
-19% -$2.59M 0.06% 163
2017
Q1 		$14.3M Buy
52,253
+20,400
+64% +$5.77M 0.07% 141
2016
Q4 		$9.03M Sell
31,853
-54,078
-63% -$16M 0.05% 178
2016
Q3 		$26.9M Buy
85,931
+32,235
+60% +$9.55M 0.1% 134
2016
Q2 		$13M Buy
53,696
+6,628
+14% +$1.75M 0.05% 212
2016
Q1 		$12.3M Sell
47,068
-5,296
-10% -$1.4M 0.05% 209
2015
Q4 		$16M Sell
52,364
-21,239
-29% -$6.1M 0.07% 162
2015
Q3 		$21.5M Buy
73,603
+776
+1% +$256K 0.09% 130
2015
Q2 		$29.4M Sell
72,827
-17,920
-20% -$7.19M 0.11% 106
2015
Q1 		$38.3M Buy
90,747
+25,656
+39% +$10.1M 0.15% 100
2014
Q4 		$22.1M Buy
65,091
+31,292
+93% +$10.1M 0.08% 145
2014
Q3 		$11.2M Sell
33,799
-13,206
-28% -$4.35M 0.04% 216
2014
Q2 		$14.8M Sell
47,005
-5,423
-10% -$1.63M 0.05% 192
2014
Q1 		$16M Buy
52,428
+6,450
+14% +$2.05M 0.06% 180
2013
Q4 		$12.9M Sell
45,978
-24,819
-35% -$6.42M 0.05% 201
2013
Q3 		$17M Sell
70,797
-14,241
-17% -$3.19M 0.06% 168
2013
Q2 		$18.3M Buy
+85,038
New +$18.2M 0.07% 150

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

I.G. Investment Management's BIIB Position: Q3 2017 in Review

I.G. Investment Management increased its Biogen (BIIB) stake by 98% in Q3 2017, buying an estimated $12.3M and bringing the position to 83,950 shares worth $26.3M. The position accounts for 0.13% of the portfolio, ranked #95.

I.G. Investment Management first reported a position in BIIB in Q2 2013 and has held it in 18 quarters since. The position peaked at $38.3M in Q1 2015. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • I.G. Investment Management held 83,950 shares of Biogen worth $26.3M as of Q3 2017.
  • I.G. Investment Management bought 41,497 Biogen shares in Q3 2017, an estimated $12.3M.
  • Biogen made up 0.13% of I.G. Investment Management's portfolio in Q3 2017, its #95 holding.
  • I.G. Investment Management first reported a position in Biogen in Q2 2013 and has held it in 18 quarters since.
  • I.G. Investment Management's Biogen position peaked at $38.3M in Q1 2015.
  • 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on I.G. Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.